Abstract: SA-PO1074
Clinical and Biological Comparison Between Nurse-Assisted Home Hemodialysis (NAHHD) and In-Center Hemodialysis (CHD) in Home-Bound and Multicomorbid Hemodialysis Patients: One-Year Results
Session Information
- Home Hemodialysis
November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 702 Dialysis: Home Hemodialysis
Authors
- Bernieh, Bassam O., HHD Home Healthcare, Abu Dhabi, United Arab Emirates
- Gogoi, Satarupa, HHD Home Healthcare, Abu Dhabi, United Arab Emirates
- Ahmed, Ahmed AM, Tawam Hospital, Al Ain, United Arab Emirates
- Hernandez, Bienmelyn Lagasca, HHD Home Healthcare, Abu Dhabi, United Arab Emirates
- Ramos, Teena Jade, HHD Home Healthcare, Abu Dhabi, United Arab Emirates
Background
Home hemodialysis (HHD) is a renal replacement modality used to treat active, autonomous, and relatively, healthy dialysis patients. The steady increase in the number of dialysis patients, with multi-comorbidities and limited mobility is creating a significant burden on the active hospital beds, and on the outpatient dialysis units. The clinical and biological outcome, of treating those highly comorbid and disabled dialysis patients with nurse assisted home hemodialysis (NAHHD) at home compared to in-center HD, is unknown. We are reporting the results of one year on NAHHD, compared to one year in CHD.
Methods
The data of 19 patients, treated in center hemodialysis (CHD) for average period of 12 months (4-14), was compared retrospectively, to average period of 12 months (4-25), on (NAHHD) for the same set of patients. All patients were dialyzed by Fresenius 5008 machine in center and by NxStage System One Cycler at home. Reasons for shifting patients to NAHHD program were: bed-confinement/ limited mobility in 12 (63%), morbid obesity in 3 (16%), psychiatric disorder/ mental retardation in 3 (16%), and others 1(5%).
Results
The mean age of the patients was 69.33 ± 12.08 (42-90) years. Etiology of ESKD was DM in 15(79%), HTN in 3(16%) and others 1(5%). The average number of comorbidities was 9.6 ± 3.07 (6-16).Vascular Access type: AVF 9(48%), AVG 1(5%), PC 7(37%), and AVG/PC/AVF 2(10%). The comparison between the results while in CHD and during NAHHD are illustrated in the Table.
Conclusion
In home bound and multi comorbid hemodialysis patients; NAHHD by using NxStage System One cycler, is safe, efficient, with better clinical and biological outcome, compared to in center HD.